CD86 and pulmonary fibrosis: However, studies in a bleomycin model of pulmonary fibrosis by Soler’s group demonstrated a sustained increase in CD11c+/MHC II+ dendritic cells and increased expression of MHC II and CD86 throughout the fibrotic stage of bleomycin-induced disease [18].